NCT02316613 Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE) Status COMPLETED Phase N/A
NCT02314481 Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity Status COMPLETED Phase PHASE2
NCT02308761 A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT02305628 An Observational Study of Herceptin SC Safety in Breast Cancer Status COMPLETED Phase N/A
NCT02305615 An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC) Status COMPLETED Phase N/A
NCT02304809 Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02304393 A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02302807 A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] Status COMPLETED Phase PHASE3
NCT02298153 A Study of Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma Status TERMINATED Phase PHASE1
NCT02291289 A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2
NCT02289833 A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT02287597 An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice Status COMPLETED Phase N/A
NCT02286362 An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer Status COMPLETED Phase N/A
NCT02286089 Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02274376 Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer Status COMPLETED Phase N/A
NCT02268929 A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients. Status COMPLETED Phase NA
NCT02266173 Observational Study of Pertuzumab Safety in Participants With Breast Cancer Status COMPLETED Phase N/A